author-photo

Andrea B. McMurphy

Baylor College of Medicine

2

Papers

144

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Erratum: Epidermal Growth Factor Receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer (Clinical Cancer Research(2004)10(8594–602)Doi:10.1158/1078-0432.CCR-04-0690)

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

2004 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (141)